|
Market Closed -
Toronto S.E.
11:22:20 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.0200 CAD | +33.33% |
|
+33.33% | -20.00% |
| Market Cap | 1.22M 882K 757K 710K 649K 84.11M 1.23M 8.41M 3.26M 42.43M 3.31M 3.24M 141M | P/E 2024 |
-40.5x | P/E 2025 | -5.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.22M 1.6M 1.37M 1.29M 1.18M 153M 2.23M 15.27M 5.92M 77.06M 6.01M 5.88M 255M | EV / Sales 2024 |
929,496,174x | EV / Sales 2025 | - |
| Free-Float |
53.08% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +33.33% | ||
| 1 week | +33.33% | ||
| Current month | +33.33% | ||
| 1 month | +33.33% | ||
| 3 months | +33.33% | ||
| Current year | -20.00% |
| 1 week | 0.02 | 0.02 | |
| 1 month | 0.02 | 0.02 | |
| Current year | 0.02 | 0.02 | |
| 1 year | 0.02 | 0.04 | |
| 3 years | 0.02 | 0.09 | |
| 5 years | 0.02 | 0.2 | |
| 10 years | 0.01 | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 57 | 2018-08-02 |
Mahmoud Aziz
PSD | President | - | 2021-05-20 |
Kevin Bottomley
PRN | Corporate Officer/Principal | 44 | 2019-09-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
BRD | Director/Board Member | 57 | 2018-08-02 |
Jamie Lewin
BRD | Director/Board Member | 76 | 2019-03-10 |
Kevin Bottomley
BRD | Director/Board Member | 44 | 2019-09-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/9/25 | Option | Chairman | 1,000,000 | 1.6885% | ||
| 9/9/25 | Option | Chairman | 1,000,000 | 1.6885% | ||
| 9/9/25 | Option | Chief Executive Officer | 1,000,000 | 1.6885% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +33.33% | +33.33% | -33.33% | -66.67% | 885K | ||
| -1.17% | -0.03% | +18.70% | +70.05% | 48.37B | ||
| +0.04% | +1.41% | +54.88% | +122.68% | 39.88B | ||
| -1.36% | -1.36% | -11.21% | +14.14% | 12.05B | ||
| +2.27% | +4.12% | +16.41% | +81.30% | 11.77B | ||
| +0.19% | 0.00% | +30.98% | +150.00% | 9.19B | ||
| -0.45% | +3.26% | +24.53% | +45.36% | 7.87B | ||
| -1.26% | +0.08% | +52.63% | -11.77% | 7.25B | ||
| +1.60% | +8.54% | +25.00% | +217.84% | 7.1B | ||
| +0.95% | -8.22% | -39.88% | +16.67% | 5.26B | ||
| Average | +3.42% | +0.62% | +13.87% | +63.96% | 14.87B | |
| Weighted average by Cap. | -0.27% | +1.17% | +26.75% | +85.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0 0 0 0 0 0.28 0 0.03 0.01 0.14 0.01 0.01 0.46 | - |
| Net income | -73.2K -52.71K -45.24K -42.46K -38.78K -5.03M -73.55K -503K -195K -2.54M -198K -194K -8.4M | -335K -241K -207K -194K -178K -23.01M -337K -2.3M -891K -11.61M -906K -886K -38.45M |
| Net Debt | 804K 579K 497K 467K 426K 55.24M 808K 5.52M 2.14M 27.87M 2.17M 2.13M 92.3M | 999K 720K 618K 580K 529K 68.64M 1M 6.86M 2.66M 34.63M 2.7M 2.64M 115M |
Employees
4,000
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- GENX Stock
Select your edition
All financial news and data tailored to specific country editions
















